论文部分内容阅读
本文用国产培氟沙星对多种感染性疾病进行临床疗效观察。采用随机分组对照,治疗各种感染38例,并于同期用头孢氨苄治疗呼吸道感染,诺氟沙星治疗肠道及泌尿道感染36例进行比较。培氟沙星治疗呼吸道、肠道及泌尿道感染的临床有效率分别为90％、92.9％和88.9％,细菌阴转率为100％、100％和88.9％;使用头孢氨苄和诺氟沙星的对照组临床有效率分别为90％、57.1％和77.8％,细菌阴转率为100％,78.5％和77.8％。结果显示培氟沙星在肠道感染中疗效优于对照组,其它各组疗效与对照组无显著差异。本品副反应发生率为16.2％。
In this paper, the domestic pefloxacin clinical observation of a variety of infectious diseases. A randomized controlled group was used to treat 38 cases of various infections. In the same period, cefalexin was used to treat respiratory tract infections and norfloxacin to treat 36 cases of intestinal and urinary tract infections. The clinical efficacies of pefloxacin in the treatment of respiratory, intestinal and urinary tract infections were 90%, 92.9% and 88.9%, respectively, and the rates of bacterial negative conversion were 100%, 100% and 88.9%, respectively. Cefalexin and norfloxacin The clinical effective rates of the control group were 90%, 57.1% and 77.8% respectively. The negative rates of bacteria were 100%, 78.5% and 77.8% respectively. The results showed that pefloxacin efficacy in the intestinal infection is better than the control group, the other groups no significant difference in the efficacy of the control group. The side effects of this product was 16.2%.